Provided by Tiger Trade Technology Pte. Ltd.

TEMA ONCOLOGY ETF

44.35
-0.2406-0.54%
Post-market: 44.450.0967+0.22%19:30 EDT
Volume:16.59K
Turnover:734.60K
Market Cap:214.67M
PE:- -
High:44.71
Open:44.71
Low:43.60
Close:44.59
52wk High:47.00
52wk Low:26.29
Shares:4.84M
Float Shares:4.84M
Volume Ratio:0.60
T/O Rate:0.34%
Dividend:0.02
Dividend Rate:0.04%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Septerna Q2 Revenue Beats Analyst Estimates, Driven by Novo Nordisk Partnership

Reuters
·
Aug 11

MHRA authorizes Eli Lilly’s weight loss pill Foundayo in UK

TIPRANKS
·
Aug 11

Eli Lilly and Co Stock (LLY) Moved Up by 3.48% on Aug 10: Drivers Behind the Movement

TradingKey
·
Aug 11

Eli Lilly Rises After UK Regulator Approves Weight-Loss Drug

Reuters
·
Aug 11

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

Cogent Biosciences Q2 Loss Widens

MT Newswires Live
·
Aug 10

Cogent Biosciences Q2 Net Income USD -96.405 Million

Reuters
·
Aug 10

Cogent Biosciences Q2 Operating Expenses USD 102.638 Million

THOMSON REUTERS
·
Aug 10

Analysts’ Top Healthcare Picks: Xencor (XNCR), Revolution Medicines (RVMD)

TIPRANKS
·
Aug 10

UK Green Lights Lilly's Obesity Pill

Reuters
·
Aug 10

UK’s MHRA Authorises Orforglipron for Weight Management and Type 2 Diabetes

Reuters
·
Aug 10

BeOne Medicines partners with Revolution Medicines for clinical development

TIPRANKS
·
Aug 10

BeOne Medicines Teams with Revolution Medicines on RAS Cancer Drug Development, Asia Rights Deal

Reuters
·
Aug 10

Beone Medicines - Receives Exclusive Rights to Four Revolution Medicines Assets in Select Asian Markets

THOMSON REUTERS
·
Aug 10

Beone Medicines - to Fund and Conduct Global Phase 3 Study for Ras(on) Inhibitor

THOMSON REUTERS
·
Aug 10

Beone Medicines - Revolution Medicines Eligible for Milestone Payments and Tiered Royalties in Partnered Region

THOMSON REUTERS
·
Aug 10

Analysts Conflicted on These Healthcare Names: Evolent Health (EVH), Eli Lilly & Co (LLY) and BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Aug 10

Revolution Medicines, Inc. : JP Morgan Raises Target Price to $227 from $205

THOMSON REUTERS
·
Aug 10

Nvidia, Eli Lilly, and Disney Show It's Time to Back the Top Dogs

Dow Jones
·
Aug 10

Analysts Are Bullish on These Healthcare Stocks: Spyre Therapeutics (SYRE), Revolution Medicines (RVMD)

TIPRANKS
·
Aug 08